Evidence map›Paper›PMID 25688987›Full record

ArticleJournal of cellular and molecular medicine2015

Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway.

Mingming Zhang, Dongdong Sun, Shuang Li, Xietian Pan, Xiaotian Zhang, Di Zhu, Congye Li, Rongqing Zhang, Erhe Gao, Haichang Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mingming ZhangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Dongdong SunDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Shuang LiDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xietian PanDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiaotian ZhangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Di ZhuDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Congye LiDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Rongqing ZhangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Erhe GaoCenter for Translational Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Haichang WangDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xijing Hospital · CNAir Force Medical University · CNTemple University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The insulin-PI3K-mTOR pathway exhibits a variety of cardiovascular activities including protection against I/R injury. Lin28a enhanced glucose uptake and insulin-sensitivity via insulin-PI3K-mTOR signalling pathway. However, the role of lin28a on experimental cardiac I/R injury in diabetic mice are not well understood. Diabetic mice underwent 30 min. of ischaemia followed by 3 hrs of reperfusion. Animals were randomized to be treated with lentivirus carrying lin28a siRNA (siLin28a) or lin28a cDNA (Lin28a) 72 hrs before coronary artery ligation. Myocardial infarct size (IS), cardiac function, cardiomyocyte apoptosis and mitochondria morphology in diabetic mice who underwent cardiac I/R injury were compared between groups. The target proteins of lin28a were examined by western blot analysis. Lin28a overexpression significantly reduced myocardial IS, improved LV ejection fraction (LVEF), decreased myocardial apoptotic index and alleviated mitochondria cristae destruction in diabetic mice underwent cardiac I/R injury. Lin28a knockdown exacerbated cardiac I/R injury as demonstrated by increased IS, decreased LVEF, increased apoptotic index and aggravated mitochondria cristae destruction. Interestingly, pre-treatment with rapamycin abolished the beneficial effects of lin28a overexpression. Lin28a overexpression increased, while Lin28a knockdown decreased the expression of IGF1R, p-Akt, p-mTOR and p-p70s6k after cardiac I/R injury in diabetic mice. Rapamycin pre-treatment abolished the effects of increased p-mTOR and p-p70s6k expression exerted by lin28a overexpression. This study indicates that lin28a overexpression reduces IS, improves cardiac function, decreases cardiomyocyte apoptosis index and alleviates cardiomyocyte mitochondria impairment after cardiac I/R injury in diabetic mice. The mechanism responsible for the effects of lin28a is associated with the insulin-PI3K-mTOR dependent pathway.

Indexed as

AnimalsApoptosisBlotting, WesternCytokinesDiabetes Mellitus, ExperimentalGene ExpressionHeartHypoglycemic AgentsInsulinMaleMice, Inbred C57BLMicroRNAsMyocardial Reperfusion InjuryMyocardiumPhosphatidylinositol 3-KinasesPhosphorylationCytokinesHypoglycemic AgentsInsulinLin-28 protein, mouseMicroRNAsmirnlet7 microRNA, mousemTOR protein, mousePhosphatidylinositol 3-KinasesProtective AgentsProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 70-kDaRNA-Binding ProteinsSirolimusTOR Serine-Threonine Kinasesdiabetesischaemia/reperfusion injuryLin28a

Identifiers

PMID25688987
PMCPMC4459833
OpenAlexW2039036006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.